Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Schwab US Dividend Equity ETF (SCHD) vs Tilray Brands Inc (TLRY) Price & Performance

Schwab US Dividend Equity ETFTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Schwab US Dividend Equity ETF vs Tilray Brands Inc — how do they compare? Schwab US Dividend Equity ETF trades at $34.23, while Tilray Brands Inc trades at $4.21 (market cap $577.15M). The key difference: Schwab US Dividend Equity ETF is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.

SCHDTLRY
Sector
Broad Market / FactorHealth
52-Week High
$35.21$21.00
52-Week Low
$26.44$3.88
Market Cap
$577.15M
Enterprise Value
$744.29M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Schwab US Dividend Equity ETF

SCHD trades at $34.41, down 1.12% over the past day, with technical indicators showing a mixed but overall bullish bias. The ETF's recent dividend announcement for June 2026 highlights its income focus, while news coverage emphasizes its role in retirement portfolios and comparisons with peers like JEPI. Support and resistance levels are tightly clustered around $34-$35, indicating potential for near-term consolidation.

The outlook for SCHD remains favorable for dividend-focused investors, supported by strong inflows and media optimism, though risks include market volatility and competition from other income ETFs. Its low expense ratio and quality screening process continue to attract long-term holders seeking steady income and moderate growth.

Tilray Brands Inc

TLRY trades at $4.30, down 4.44% with a bearish technical outlook. The company reported record fiscal 2026 revenue of $915M but continues to post significant losses with a -13.27% net margin. Recent news highlights expansion in spirits distribution and medical cannabis production, though regulatory uncertainty weighs on sentiment. The stock trades below book value with a P/S of 0.51 and P/B of 0.36, suggesting potential undervaluation despite profitability challenges.

TLRY presents a high-risk opportunity with mixed signals. The discounted valuation and expanding beverage/alcohol business offer upside potential, but persistent losses, negative cash flow, and cannabis regulatory delays create substantial headwinds. Analyst consensus leans cautious with 65% hold ratings, reflecting the stock's speculative nature amid ongoing operational challenges.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Schwab US Dividend Equity ETF

SCHD is an ETF that tracks the Dow Jones U.S. Dividend 100 Index. It selects high-quality companies with a consistent track record of paying dividends, focusing on financial strength metrics like cash flow to total debt and return on equity, and excluding REITs. The fund aims to provide both income and capital appreciation, making it a popular choice for long-term, dividend-focused investors.

Read more on SCHD

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY